There are 2949 resources available
636P - A study of sustained androgen signaling dependence in metastatic castrate resistant prostate cancer (mCRPC)
Presenter: Myrto Boukovala
Session: E-Poster Display
Resources:
Abstract
637P - The prognostic value of the baseline neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223): A post-hoc analysis of the ALSYMPCA phase-III trial
Presenter: Alexander Meisel
Session: E-Poster Display
Resources:
Abstract
638P - Meningeal metastases (MM) in patients with metastatic castration resistant prostate cancer (mCRPC)
Presenter: Mihaela Aldea
Session: E-Poster Display
Resources:
Abstract
639P - 223Ra in asymptomatic patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who progressed to first-line abiraterone acetate or enzalutamide
Presenter: Joan Carles
Session: E-Poster Display
Resources:
Abstract
640P - Quality of life and survival in elderly metastatic castration-resistant prostate cancer (mCRPC) patients (Pts) treated with docetaxel
Presenter: Irene Paredero Perez
Session: E-Poster Display
Resources:
Abstract
641P - Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Neal Shore
Session: E-Poster Display
Resources:
Abstract
642P - Role of free testosterone serum levels during salvage chemotherapy with carboplatin plus weekly docetaxel in patients with docetaxel-refractory, metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Christoph Reuter
Session: E-Poster Display
Resources:
Abstract
643P - Evaluating biomarkers in metastatic castration resistant prostate cancer (mCRPC) patients (Pts) treated with enzalutamide (Enza): PSA, circulating tumor cell (CTC) counts, AR-V7 status, PET imaging vs. CT & Tc99 scans
Presenter: Shruti Gandhy
Session: E-Poster Display
Resources:
Abstract
644P - BRCA2 status and intraductal [IDC] and cribriform [CRIB] histologic variants: Partners in prostate cancer (PC)?
Presenter: Nuria Romero Laorden
Session: E-Poster Display
Resources:
Abstract
645P - Prediction of BRCA2 mutations in prostate cancer patients according early onset, metastatic phenotypes or family history of breast/ovary cancer
Presenter: Geraldine Cancel-Tassin
Session: E-Poster Display
Resources:
Abstract